SCHEMBL4048665

SCHEMBL4048665

CC1(C)Cc2c(N3CCCC3)nc3sc4c(Cl)ncnc4c3c2C1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.56
ALDH1A1 P00352 3/20 0.56
POLB P06746 2/20 0.56
PDE4B Q07343 6/20 0.55
PDE4A P27815 3/20 0.52
PDE4D Q08499 3/20 0.52
MAPT P10636 3/20 0.52
ADRB2 P07550 2/20 0.52
KMT2A Q03164 3/20 0.51
RAD52 P43351 2/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
CHRM4 P08173 5/20 0.50
OPRK1 P41145 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49
HTT P42858 2/20 0.49
NSD2 O96028 1/20 0.49
RECQL P46063 1/20 0.49
LMNA P02545 1/20 0.47
AGTR1 P30556 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4048395 0.92 PDE4B (0.62) KDM4EALDH1A1POLBPDE4BPDE4A
SCHEMBL4046032 0.90 PDE4B (0.67) KDM4EALDH1A1PDE4BPDE4APDE4D
SCHEMBL5011383 0.86 ALDH1A1 (0.75) KDM4EALDH1A1POLBPDE4BPDE4A
SCHEMBL5013141 0.86 ALDH1A1 (0.73) KDM4EALDH1A1POLBPDE4BPDE4A
SCHEMBL4047482 0.85 KDM4E (0.54) KDM4EALDH1A1POLBPDE4BPDE4A
SCHEMBL4048607 0.83 PDE4B (0.64) KDM4EALDH1A1POLBPDE4BPDE4A
SCHEMBL4048329 0.83 PDE4B (0.56) KDM4EALDH1A1POLBPDE4BPDE4A
SCHEMBL4057386 0.83 PDE4B (0.69) KDM4EALDH1A1PDE4BPDE4APDE4D
SCHEMBL4045515 0.81 POLB (0.52) KDM4EALDH1A1POLBPDE4BPDE4A
SCHEMBL5013083 0.79 TSHR (0.71) KDM4EALDH1A1POLBPDE4BPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1819710-B1 NEW PYRIDOTHIENOPYRIMIDINE DERIVATIVES ALMIRALL LAB (ES) 2009-03-11 EP disclosed
US-20090029955-A1 Pyridothienopyrimidine Derivatives ALMIRALL PRODESFARMA S.A. (ES) 2009-01-29 US disclosed
EP-1819710-A1 NEW PYRIDOTHIENOPYRIMIDINE DERIVATIVES Laboratorios Almirall, S.A. (ES) 2007-08-22 EP disclosed
WO-2006058724-A1 NEW PYRIDOTHIENOPYRIMIDINE DERIVATIVES LABORATORIOS ALMIRALL, S.A. (ES) 2006-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029955-A1 Pyridothienopyrimidine Derivatives PNPO, PDE4A, DPYD KDM4E 1600/4885ALDH1A1 391/4885POLB 378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.